South Denver Cardiology
Back to Trials

BEAT

Short Description

Phase 3 study to assess the efficacy and safety of oral BPS-314d-MR

BEAT: A multicenter, double-blind, randomized, placebo-controlled, Phase 3 study to assess the efficacy

and safety of oral BPS-314d-MR (oral Tyvaso) added-on to treprostinil, inhaled (Tyvaso®) in subjects with

PAH.

Questions: Call Mary Soltau 303-703-2191 or Rebecca Wimmer 303-715-2275

South Denver Cardiology
Latest posts by South Denver Cardiology (see all)

Recommend

  • This field is for validation purposes and should be left unchanged.
  • MM slash DD slash YYYY
  • What questions do you have regarding your bill?